US Stock MarketDetailed Quotes

NMRD Nemaura Medical

Watchlist

0.000
0.0000.00%

15min DelayClose Nov 14 16:00 ET

40.35Market Cap0.00P/E (TTM)

Nemaura Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

(FY)Mar 31, 2022

(Q4)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.99%-1.48M

-47.94%-3.2M

-5.75%-2.52M

-29.95%-8.45M

-9.81%-2.36M

-75.64%-1.54M

-21.21%-2.16M

-41.07%-2.38M

-8.44%-6.5M

-58.21%-2.15M

Net income from continuing operations

-25.94%-2.16M

68.79%-1.2M

33.06%-2.6M

-1.85%-14.14M

-29.46%-4.68M

49.99%-1.72M

-10.34%-3.86M

-16.30%-3.89M

-121.88%-13.89M

-69.77%-3.62M

Operating gains losses

-31.79%-1.31M

-312.59%-1.67M

-113.35%-112.08K

-457.22%-1.57M

-1,017.41%-2.21M

-1,297.52%-990.54K

--786.45K

--839.58K

--440.2K

--240.67K

Depreciation and amortization

-16.15%80.43K

77.53%131.17K

-0.72%98.09K

93.28%444.18K

94.96%175.58K

65.20%95.92K

62.18%73.89K

173.41%98.79K

134.32%229.81K

202.57%90.06K

Other non cash items

59.88%1.73M

-106.01%-97.25K

-54.75%657.01K

-3.75%6.42M

48.47%2.26M

-33.93%1.08M

-9.10%1.62M

-15.73%1.45M

232.06%6.67M

40.28%1.52M

Change In working capital

1,435.34%175.56K

40.82%-465.81K

36.63%-561.19K

-1,075.35%-2.05M

39.57%-368.56K

-101.42%-13.15K

-103.26%-787.04K

-739.52%-885.63K

91.08%-174.79K

-62.77%-609.88K

-Change in receivables

----

508.68%1.02M

----

---250.09K

----

-Change in inventory

-71.81%-760.14K

-133.33%-664.55K

-334.13%-596.43K

-173.91%-1.75M

-750.83%-880.55K

-64.44%-442.44K

-22.23%-284.81K

-335.00%-137.39K

-12.91%-637.15K

-219.56%-103.49K

-Change in prepaid assets

-70.78%209.47K

140.90%338.97K

259.12%565.41K

-103.35%-17.42K

261.86%449.66K

-19.64%716.93K

-282.02%-828.67K

35.42%-355.33K

167.71%519.35K

24.74%-277.81K

-Change in payables and accrued expense

116.13%84.07K

-92.90%39.28K

132.16%52.88K

-222.95%-237.42K

-118.33%-104.75K

-238.53%-521.14K

257.00%552.89K

59.15%-164.42K

126.78%193.11K

456.94%571.57K

-Change in other working capital

----

-155.17%-583.05K

---1.08M

---854.99K

139.48%72.85K

-43.20%-65.8K

-144.30%-228.49K

----

Cash from discontinued investing activities

Operating cash flow

3.99%-1.48M

-47.94%-3.2M

-5.75%-2.52M

-29.95%-8.45M

-9.81%-2.36M

-75.64%-1.54M

-21.21%-2.16M

-41.07%-2.38M

-8.44%-6.5M

-58.21%-2.15M

Investing cash flow

Cash flow from continuing investing activities

81.91%-10.43K

77.26%-37.17K

86.59%-29.21K

43.62%-539.22K

-31.30%-100.41K

70.25%-57.64K

43.25%-163.46K

45.33%-217.71K

-14.35%-956.48K

71.80%-76.47K

Capital expenditure reported

--0

-61.51%-135.17K

218.89%27.88K

171.60%9.18K

180.50%19.89K

-745.80%-192.11K

-2.12%-83.69K

30.37%-23.45K

Net PPE purchase and sale

84.39%-10.43K

79.73%-37.17K

-14.09%-29.21K

21.91%-376.17K

17.98%-100.41K

52.02%-66.81K

-33.04%-183.35K

68.87%-25.6K

-430.94%-481.72K

-506.54%-122.42K

Net intangibles purchase and sale

----

92.87%-27.88K

----

41.08%-391.07K

131.93%69.39K

Cash from discontinued investing activities

Investing cash flow

81.91%-10.43K

77.26%-37.17K

86.59%-29.21K

43.62%-539.22K

-31.30%-100.41K

70.25%-57.64K

43.25%-163.46K

45.33%-217.71K

-14.35%-956.48K

71.80%-76.47K

Financing cash flow

Cash flow from continuing financing activities

-76.51%-3M

361.45%3.92M

-4,746.40%-3.6M

132.69%2.08M

281.78%5.36M

34.27%-1.7M

34.78%-1.5M

-105.08%-74.28K

-116.76%-6.37M

-115.92%-2.95M

Net issuance payments of debt

-76.47%-3M

361.45%3.92M

-4,746.40%-3.6M

55.05%-5.57M

61.02%-2.3M

37.04%-1.7M

34.78%-1.5M

95.05%-74.28K

-150.82%-12.4M

-129.95%-5.9M

Net common stock issuance

----

169.14%8.39M

179.78%8.39M

----

-80.20%3.12M

--3M

Proceeds from stock option exercised by employees

----

--0

----

639.98%2.96M

--0

Net other financing activities

----

-1,353.08%-737.66K

-1,489.77%-737.39K

----

98.02%-50.77K

96.13%-46.38K

Cash from discontinued financing activities

Financing cash flow

-76.51%-3M

361.45%3.92M

-4,746.40%-3.6M

132.69%2.08M

281.78%5.36M

34.27%-1.7M

34.78%-1.5M

-105.08%-74.28K

-116.76%-6.37M

-115.92%-2.95M

Net cash flow

Beginning cash position

-56.69%4.38M

-72.82%4.01M

-43.07%10.11M

-44.30%17.75M

-68.15%7.34M

-62.23%10.11M

-52.81%14.75M

-44.30%17.75M

29,931.36%31.87M

54.05%23.05M

Current changes in cash

-36.13%-4.49M

117.81%681.78K

-129.83%-6.15M

50.04%-6.91M

155.94%2.89M

9.80%-3.3M

12.48%-3.83M

-328.46%-2.68M

-144.39%-13.83M

-130.66%-5.17M

Effect of exchange rate changes

-52.94%249.19K

61.51%-313.26K

117.15%55.09K

-155.91%-735.22K

-4.87%-129.67K

912.63%529.5K

-592.75%-813.79K

-1,793.26%-321.26K

-147.30%-287.3K

-510.89%-123.64K

End cash Position

-98.13%137.42K

-56.69%4.38M

-72.82%4.01M

-43.07%10.11M

-68.15%7.34M

-62.23%10.11M

-52.81%14.75M

-44.30%17.75M

Free cash flow

6.80%-1.49M

-39.15%-3.24M

1.97%-2.55M

-20.51%-8.99M

-10.55%-2.46M

-49.25%-1.6M

-12.26%-2.33M

-24.60%-2.6M

-9.16%-7.46M

-36.59%-2.23M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022	(FY)Mar 31, 2022	(Q4)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.99%-1.48M	-47.94%-3.2M	-5.75%-2.52M	-29.95%-8.45M	-9.81%-2.36M	-75.64%-1.54M	-21.21%-2.16M	-41.07%-2.38M	-8.44%-6.5M	-58.21%-2.15M
Net income from continuing operations	-25.94%-2.16M	68.79%-1.2M	33.06%-2.6M	-1.85%-14.14M	-29.46%-4.68M	49.99%-1.72M	-10.34%-3.86M	-16.30%-3.89M	-121.88%-13.89M	-69.77%-3.62M
Operating gains losses	-31.79%-1.31M	-312.59%-1.67M	-113.35%-112.08K	-457.22%-1.57M	-1,017.41%-2.21M	-1,297.52%-990.54K	--786.45K	--839.58K	--440.2K	--240.67K
Depreciation and amortization	-16.15%80.43K	77.53%131.17K	-0.72%98.09K	93.28%444.18K	94.96%175.58K	65.20%95.92K	62.18%73.89K	173.41%98.79K	134.32%229.81K	202.57%90.06K
Other non cash items	59.88%1.73M	-106.01%-97.25K	-54.75%657.01K	-3.75%6.42M	48.47%2.26M	-33.93%1.08M	-9.10%1.62M	-15.73%1.45M	232.06%6.67M	40.28%1.52M
Change In working capital	1,435.34%175.56K	40.82%-465.81K	36.63%-561.19K	-1,075.35%-2.05M	39.57%-368.56K	-101.42%-13.15K	-103.26%-787.04K	-739.52%-885.63K	91.08%-174.79K	-62.77%-609.88K
-Change in receivables	----	----	----	508.68%1.02M	----	----	----	----	---250.09K	----
-Change in inventory	-71.81%-760.14K	-133.33%-664.55K	-334.13%-596.43K	-173.91%-1.75M	-750.83%-880.55K	-64.44%-442.44K	-22.23%-284.81K	-335.00%-137.39K	-12.91%-637.15K	-219.56%-103.49K
-Change in prepaid assets	-70.78%209.47K	140.90%338.97K	259.12%565.41K	-103.35%-17.42K	261.86%449.66K	-19.64%716.93K	-282.02%-828.67K	35.42%-355.33K	167.71%519.35K	24.74%-277.81K
-Change in payables and accrued expense	116.13%84.07K	-92.90%39.28K	132.16%52.88K	-222.95%-237.42K	-118.33%-104.75K	-238.53%-521.14K	257.00%552.89K	59.15%-164.42K	126.78%193.11K	456.94%571.57K
-Change in other working capital	----	----	-155.17%-583.05K	---1.08M	---854.99K	139.48%72.85K	-43.20%-65.8K	-144.30%-228.49K	----	----
Cash from discontinued investing activities
Operating cash flow	3.99%-1.48M	-47.94%-3.2M	-5.75%-2.52M	-29.95%-8.45M	-9.81%-2.36M	-75.64%-1.54M	-21.21%-2.16M	-41.07%-2.38M	-8.44%-6.5M	-58.21%-2.15M
Investing cash flow
Cash flow from continuing investing activities	81.91%-10.43K	77.26%-37.17K	86.59%-29.21K	43.62%-539.22K	-31.30%-100.41K	70.25%-57.64K	43.25%-163.46K	45.33%-217.71K	-14.35%-956.48K	71.80%-76.47K
Capital expenditure reported	--0	--0	--0	-61.51%-135.17K	218.89%27.88K	171.60%9.18K	180.50%19.89K	-745.80%-192.11K	-2.12%-83.69K	30.37%-23.45K
Net PPE purchase and sale	84.39%-10.43K	79.73%-37.17K	-14.09%-29.21K	21.91%-376.17K	17.98%-100.41K	52.02%-66.81K	-33.04%-183.35K	68.87%-25.6K	-430.94%-481.72K	-506.54%-122.42K
Net intangibles purchase and sale	----	----	----	92.87%-27.88K	----	----	----	----	41.08%-391.07K	131.93%69.39K
Cash from discontinued investing activities
Investing cash flow	81.91%-10.43K	77.26%-37.17K	86.59%-29.21K	43.62%-539.22K	-31.30%-100.41K	70.25%-57.64K	43.25%-163.46K	45.33%-217.71K	-14.35%-956.48K	71.80%-76.47K
Financing cash flow
Cash flow from continuing financing activities	-76.51%-3M	361.45%3.92M	-4,746.40%-3.6M	132.69%2.08M	281.78%5.36M	34.27%-1.7M	34.78%-1.5M	-105.08%-74.28K	-116.76%-6.37M	-115.92%-2.95M
Net issuance payments of debt	-76.47%-3M	361.45%3.92M	-4,746.40%-3.6M	55.05%-5.57M	61.02%-2.3M	37.04%-1.7M	34.78%-1.5M	95.05%-74.28K	-150.82%-12.4M	-129.95%-5.9M
Net common stock issuance	----	----	----	169.14%8.39M	179.78%8.39M	----	----	----	-80.20%3.12M	--3M
Proceeds from stock option exercised by employees	----	----	----	--0	----	----	----	----	639.98%2.96M	--0
Net other financing activities	----	----	----	-1,353.08%-737.66K	-1,489.77%-737.39K	----	----	----	98.02%-50.77K	96.13%-46.38K
Cash from discontinued financing activities
Financing cash flow	-76.51%-3M	361.45%3.92M	-4,746.40%-3.6M	132.69%2.08M	281.78%5.36M	34.27%-1.7M	34.78%-1.5M	-105.08%-74.28K	-116.76%-6.37M	-115.92%-2.95M
Net cash flow
Beginning cash position	-56.69%4.38M	-72.82%4.01M	-43.07%10.11M	-44.30%17.75M	-68.15%7.34M	-62.23%10.11M	-52.81%14.75M	-44.30%17.75M	29,931.36%31.87M	54.05%23.05M
Current changes in cash	-36.13%-4.49M	117.81%681.78K	-129.83%-6.15M	50.04%-6.91M	155.94%2.89M	9.80%-3.3M	12.48%-3.83M	-328.46%-2.68M	-144.39%-13.83M	-130.66%-5.17M
Effect of exchange rate changes	-52.94%249.19K	61.51%-313.26K	117.15%55.09K	-155.91%-735.22K	-4.87%-129.67K	912.63%529.5K	-592.75%-813.79K	-1,793.26%-321.26K	-147.30%-287.3K	-510.89%-123.64K
End cash Position	-98.13%137.42K	-56.69%4.38M	-72.82%4.01M	-43.07%10.11M	-43.07%10.11M	-68.15%7.34M	-62.23%10.11M	-52.81%14.75M	-44.30%17.75M	-44.30%17.75M
Free cash flow	6.80%-1.49M	-39.15%-3.24M	1.97%-2.55M	-20.51%-8.99M	-10.55%-2.46M	-49.25%-1.6M	-12.26%-2.33M	-24.60%-2.6M	-9.16%-7.46M	-36.59%-2.23M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data